Covered recipient · General Payments record
SHERVIN ESHRAGHI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$63,828.82
- Reported across 1,023 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,047.05 | 12 |
| Education | $67.49 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $314.84 | 9 |
| Alexion Pharmaceuticals, Inc. | $243.66 | 2 |
| SK Life Science, Inc. | $180.66 | 3 |
| Alnylam Pharmaceuticals Inc. | $135.38 | 2 |
| ABBVIE INC. | $125.00 | 1 |
| Itamar Medical Inc | $115.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.00 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103698432 | CMS |
| Alexion Pharmaceuticals, Inc. | $121.83 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094030963 | CMS |
| Alexion Pharmaceuticals, Inc. | $121.83 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093925026 | CMS |
| Alnylam Pharmaceuticals Inc. | $111.54 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125834345 | CMS |
| Alnylam Pharmaceuticals Inc. | $23.84 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125834305 | CMS |
| Amgen Inc. | $102.44 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115606050 | CMS |
| Amgen Inc. | $11.41 | 01/29/2024 | Education | Undisputed | 01/23/2026 | 1115606059 | CMS |
| Amgen Inc. | $11.41 | 02/06/2024 | Education | Undisputed | 01/23/2026 | 1115606071 | CMS |
| Amgen Inc. | $124.99 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115606090 | CMS |
| Amgen Inc. | $13.11 | 04/12/2024 | Education | Undisputed | 01/23/2026 | 1115606082 | CMS |
| Amgen Inc. | $10.52 | 05/17/2024 | Education | Undisputed | 01/23/2026 | 1115606104 | CMS |
| Amgen Inc. | $10.52 | 06/14/2024 | Education | Undisputed | 01/23/2026 | 1115606119 | CMS |
| Amgen Inc. | $10.52 | 06/17/2024 | Education | Undisputed | 01/23/2026 | 1115606129 | CMS |
| Amgen Inc. | $19.92 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115606113 | CMS |
| Itamar Medical Inc | $115.00 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154006024 | CMS |
| SK Life Science, Inc. | $28.79 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154118566 | CMS |
| SK Life Science, Inc. | $117.56 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154118682 | CMS |
| SK Life Science, Inc. | $34.31 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154118616 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.